SCHEMBL23473645

SCHEMBL23473645

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4oc5cccc(-c6ccc7nc(-c8ccccc8)sc7c6)c5c4c3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ NFKB1 P19838 3/20 0.45
▸ NFKB2 Q00653 3/20 0.45
▸ RELA Q04206 3/20 0.45
▸ LMNA P02545 2/20 0.45
▸ APP P05067 11/20 0.44
▸ MAPT P10636 7/20 0.44
▸ GAA P10253 6/20 0.44
▸ ALDH1A1 P00352 5/20 0.44
▸ HPGD P15428 5/20 0.44
▸ GLA P06280 4/20 0.44
▸ PKM P14618 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ NPC1 O15118 5/20 0.40
▸ RAB9A P51151 5/20 0.40
▸ POLB P06746 3/20 0.40
▸ GFER P55789 2/20 0.40
▸ MITF O75030 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27107335 0.95 KDM4E (0.44) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL23473659 0.91 MAPT (0.40) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL27107345 0.91 KDM4E (0.45) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL22912396 0.90 MAPT (0.45) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL27049571 0.90 KDM4E (0.46) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL27107339 0.90 KDM4E (0.48) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL22912395 0.89 MAPT (0.46) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL27049287 0.89 KDM4E (0.47) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL22177861 0.88 MAPT (0.46) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL27107342 0.87 KDM4E (0.52) KDM4ESMN1; SMN2NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240074312-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2024-02-29 — — US disclosed
US-20240074312-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2024-02-29 — — US disclosed
US-11725138-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. 2023-08-15 — — US disclosed
US-11725138-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. 2023-08-15 — — US disclosed
US-20210175433-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2021-06-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240074312-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME MCM6, MCM2, SOD1 KDM4E 3635/4885SMN1; SMN2 1695/4885NFKB1 969/4885
US-11725138-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same OR10J3, ICOSLG, TRPM4 KDM4E 1072/4885SMN1; SMN2 2381/4885NFKB1 2883/4885
US-20210175433-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, ICOSLG, TRPM4 KDM4E 1072/4885SMN1; SMN2 2381/4885NFKB1 2883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback